19 June 2013
Keywords: amgen, submits, sbla, aranesp, biotechnology, giant, submitted
Article | 16 May 2005
US biotechnology giant Amgen has submitted a supplemental Biologics License Application to the US Food and Drug Administration for extended
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 May 2005
18 June 2013
© 2013 thepharmaletter.com